m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00659)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
LINC01273
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Browse Drug
Methyltransferase-like 3 (METTL3) [WRITER]
| Representative RIP-seq result supporting the interaction between LINC01273 and the regulator | ||
| Cell Line | MDA-MB-231 | Homo sapiens |
| Regulation | logFC: 7.26E+00 | GSE60213 |
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
| Response Summary | Long intergenic non-protein coding RNA 1273 (LINC01273) was modified with m6A, METTL3 increased LINC01273 m6A modification, followed by LINC01273 decay in the presence of YTHDF2, a m6A 'reader'. And LINC01273 plays a key role in sorafenib resistant HCC cells. | |||
| Target Regulation | Down regulation | |||
| Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
| Responsed Drug | Sorafenib | Approved | ||
| In-vitro Model | SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 |
| Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
YTH domain-containing family protein 2 (YTHDF2) [READER]
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
| Response Summary | Long intergenic non-protein coding RNA 1273 (LINC01273) was modified with m6A, METTL3 increased LINC01273 m6A modification, followed by LINC01273 decay in the presence of YTHDF2, a m6A 'reader'. And LINC01273 plays a key role in sorafenib resistant HCC cells. | |||
| Target Regulation | Down regulation | |||
| Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
| Responsed Drug | Sorafenib | Approved | ||
| In-vitro Model | SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 |
| Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
Liver cancer [ICD-11: 2C12]
| In total 2 item(s) under this disease | ||||
| Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
| Response Summary | Long intergenic non-protein coding RNA 1273 (LINC01273) was modified with m6A, METTL3 increased LINC01273 m6A modification, followed by LINC01273 decay in the presence of YTHDF2, a m6A 'reader'. And LINC01273 plays a key role in sorafenib resistant HCC cells. | |||
| Responsed Disease | Hepatocellular carcinoma [ICD-11: 2C12.02] | |||
| Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
| Target Regulation | Down regulation | |||
| Responsed Drug | Sorafenib | Approved | ||
| In-vitro Model | SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 |
| Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
| Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
| Response Summary | Long intergenic non-protein coding RNA 1273 (LINC01273) was modified with m6A, METTL3 increased LINC01273 m6A modification, followed by LINC01273 decay in the presence of YTHDF2, a m6A 'reader'. And LINC01273 plays a key role in sorafenib resistant HCC cells. | |||
| Responsed Disease | Hepatocellular carcinoma [ICD-11: 2C12.02] | |||
| Target Regulator | YTH domain-containing family protein 2 (YTHDF2) | READER | ||
| Target Regulation | Down regulation | |||
| Responsed Drug | Sorafenib | Approved | ||
| In-vitro Model | SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 |
| Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
Sorafenib
[Approved]
| In total 2 item(s) under this drug | ||||
| Experiment 1 Reporting the m6A-centered Drug Response | [1] | |||
| Response Summary | Long intergenic non-protein coding RNA 1273 (LINC01273) was modified with m6A, METTL3 increased LINC01273 m6A modification, followed by LINC01273 decay in the presence of YTHDF2, a m6A 'reader'. And LINC01273 plays a key role in sorafenib resistant HCC cells. | |||
| Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
| Target Regulation | Down regulation | |||
| Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
| In-vitro Model | SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 |
| Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
| Experiment 2 Reporting the m6A-centered Drug Response | [1] | |||
| Response Summary | Long intergenic non-protein coding RNA 1273 (LINC01273) was modified with m6A, METTL3 increased LINC01273 m6A modification, followed by LINC01273 decay in the presence of YTHDF2, a m6A 'reader'. And LINC01273 plays a key role in sorafenib resistant HCC cells. | |||
| Target Regulator | YTH domain-containing family protein 2 (YTHDF2) | READER | ||
| Target Regulation | Down regulation | |||
| Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
| In-vitro Model | SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 |
| Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Regulator
Histone modification
m6A Regulator: YTH domain-containing family protein 2 (YTHDF2)
| In total 2 item(s) under this m6A regulator | ||
| Crosstalk ID: M6ACROT03416 | ||
| Regulated Target | Histone H3 lysine 4 trimethylation (H3K4me3) | |
| Crosstalk relationship | Histone modification → m6A | |
| Disease | Liver cancer | |
| Drug | Sorafenib | |
| Crosstalk ID: M6ACROT03427 | ||
| Regulated Target | Histone H3 lysine 27 acetylation (H3K27ac) | |
| Crosstalk relationship | Histone modification → m6A | |
| Disease | Liver cancer | |
| Drug | Sorafenib | |
Non-coding RNA
m6A Regulator: YTH domain-containing family protein 2 (YTHDF2)
| In total 2 item(s) under this m6A regulator | ||
| Crosstalk ID: M6ACROT05044 | ||
| Epigenetic Regulator | MicroRNA 145 (MIR145) | |
| Regulated Target | YTH domain-containing family protein 2 (YTHDF2) | |
| Crosstalk relationship | ncRNA → m6A | |
| Disease | Liver cancer | |
| Crosstalk ID: M6ACROT05612 | ||
| Epigenetic Regulator | Long intergenic non-protein coding RNA 1273 (LINC01273) | |
| Regulated Target | hsa-miR-600 | |
| Crosstalk relationship | m6A → ncRNA | |
| Disease | Liver cancer | |
| Drug | Sorafenib | |
m6A Regulator: Methyltransferase-like 3 (METTL3)
| In total 3 item(s) under this m6A regulator | ||
| Crosstalk ID: M6ACROT05354 | ||
| Epigenetic Regulator | hsa-miR-600 | |
| Regulated Target | Methyltransferase-like protein 3 (METTL3) | |
| Crosstalk relationship | ncRNA → m6A | |
| Disease | Liver cancer | |
| Drug | Sorafenib | |
| Crosstalk ID: M6ACROT05355 | ||
| Epigenetic Regulator | Long intergenic non-protein coding RNA 1273 (LINC01273) | |
| Regulated Target | hsa-miR-600 | |
| Crosstalk relationship | ncRNA → m6A | |
| Disease | Liver cancer | |
| Drug | Sorafenib | |
| Crosstalk ID: M6ACROT05611 | ||
| Epigenetic Regulator | Long intergenic non-protein coding RNA 1273 (LINC01273) | |
| Regulated Target | hsa-miR-600 | |
| Crosstalk relationship | m6A → ncRNA | |
| Disease | Liver cancer | |
| Drug | Sorafenib | |
RNA Modification Sequencing Data Associated with the Target (ID: M6ATAR00659)
| In total 2 m6A sequence/site(s) in this target gene | |||
| mod ID: A2ISITE010722 | Click to Show/Hide the Full List | ||
| mod site | chr20:50173249-50173250:+ | [2] | |
| Sequence | CAGTGGTGCAATCCTAGCTCACTGCAGCTTCGACCTCCCGT | ||
| Transcript ID List | ENST00000427333.5; ENST00000411453.2 | ||
| External Link | RMBase: RNA-editing_site_88160 | ||
| mod ID: A2ISITE010723 | Click to Show/Hide the Full List | ||
| mod site | chr20:50173254-50173255:+ | [2] | |
| Sequence | GTGCAATCCTAGCTCACTGCAGCTTCGACCTCCCGTGCTCA | ||
| Transcript ID List | ENST00000411453.2; ENST00000427333.5 | ||
| External Link | RMBase: RNA-editing_site_88161 | ||
N6-methyladenosine (m6A)
| In total 10 m6A sequence/site(s) in this target gene | |||
| mod ID: M6ASITE053530 | Click to Show/Hide the Full List | ||
| mod site | chr20:50172745-50172746:+ | [3] | |
| Sequence | GGTTTCGGTTTTCTGGCTGAACAGTGATTAACGCGAGGGAA | ||
| Motif Score | 2.951386905 | ||
| Cell/Tissue List | HeLa; HepG2; A549; iSLK | ||
| Seq Type List | m6A-seq; MeRIP-seq | ||
| Transcript ID List | ENST00000427333.5; ENST00000411453.2; rmsk_5144549 | ||
| External Link | RMBase: m6A_site_536253 | ||
| mod ID: M6ASITE053531 | Click to Show/Hide the Full List | ||
| mod site | chr20:50172927-50172928:+ | [3] | |
| Sequence | CTTGTTTTGTCCCAGGAAGAACATTCCAACACAGACCACAA | ||
| Motif Score | 2.951386905 | ||
| Cell/Tissue List | HeLa; HepG2; A549; iSLK | ||
| Seq Type List | m6A-seq; MeRIP-seq | ||
| Transcript ID List | ENST00000411453.2; ENST00000427333.5; rmsk_5144550 | ||
| External Link | RMBase: m6A_site_536254 | ||
| mod ID: M6ASITE053532 | Click to Show/Hide the Full List | ||
| mod site | chr20:50172941-50172942:+ | [3] | |
| Sequence | GGAAGAACATTCCAACACAGACCACAACACCTATGGACCTG | ||
| Motif Score | 2.876744048 | ||
| Cell/Tissue List | HeLa; HepG2; A549; iSLK | ||
| Seq Type List | m6A-seq; MeRIP-seq | ||
| Transcript ID List | ENST00000411453.2; rmsk_5144550; ENST00000427333.5 | ||
| External Link | RMBase: m6A_site_536255 | ||
| mod ID: M6ASITE053533 | Click to Show/Hide the Full List | ||
| mod site | chr20:50172957-50172958:+ | [3] | |
| Sequence | ACAGACCACAACACCTATGGACCTGGAAAACATTGTGCTCA | ||
| Motif Score | 3.622404762 | ||
| Cell/Tissue List | HeLa; HepG2; A549 | ||
| Seq Type List | m6A-seq; MeRIP-seq | ||
| Transcript ID List | ENST00000427333.5; ENST00000411453.2; rmsk_5144550 | ||
| External Link | RMBase: m6A_site_536256 | ||
| mod ID: M6ASITE053534 | Click to Show/Hide the Full List | ||
| mod site | chr20:50172966-50172967:+ | [3] | |
| Sequence | AACACCTATGGACCTGGAAAACATTGTGCTCAGTGAAAGAA | ||
| Motif Score | 2.20572619 | ||
| Cell/Tissue List | HeLa; HepG2; A549 | ||
| Seq Type List | m6A-seq; MeRIP-seq | ||
| Transcript ID List | rmsk_5144550; ENST00000427333.5; ENST00000411453.2 | ||
| External Link | RMBase: m6A_site_536257 | ||
| mod ID: M6ASITE053535 | Click to Show/Hide the Full List | ||
| mod site | chr20:50172992-50172993:+ | [3] | |
| Sequence | TGCTCAGTGAAAGAAGCCAGACACAGAAGGACAATGTTGTA | ||
| Motif Score | 2.897386905 | ||
| Cell/Tissue List | HeLa; HepG2; A549 | ||
| Seq Type List | m6A-seq; MeRIP-seq | ||
| Transcript ID List | rmsk_5144550; ENST00000411453.2; ENST00000427333.5 | ||
| External Link | RMBase: m6A_site_536258 | ||
| mod ID: M6ASITE053536 | Click to Show/Hide the Full List | ||
| mod site | chr20:50173002-50173003:+ | [3] | |
| Sequence | AAGAAGCCAGACACAGAAGGACAATGTTGTATGAGGTACCT | ||
| Motif Score | 3.643047619 | ||
| Cell/Tissue List | HeLa; HepG2; A549 | ||
| Seq Type List | m6A-seq; MeRIP-seq | ||
| Transcript ID List | rmsk_5144550; ENST00000411453.2; ENST00000427333.5 | ||
| External Link | RMBase: m6A_site_536259 | ||
| mod ID: M6ASITE053537 | Click to Show/Hide the Full List | ||
| mod site | chr20:50173225-50173226:+ | [3] | |
| Sequence | TATTCTGTTGCCCAGGCTGGACTGCAGTGGTGCAATCCTAG | ||
| Motif Score | 4.065041667 | ||
| Cell/Tissue List | HeLa | ||
| Seq Type List | m6A-seq | ||
| Transcript ID List | ENST00000411453.2; ENST00000427333.5 | ||
| External Link | RMBase: m6A_site_536260 | ||
| mod ID: M6ASITE053538 | Click to Show/Hide the Full List | ||
| mod site | chr20:50176282-50176283:+ | [4] | |
| Sequence | GCCACATGTGTTTTGCAGGGACACATTCCAGCAAAAAGACA | ||
| Motif Score | 3.643047619 | ||
| Cell/Tissue List | Huh7 | ||
| Seq Type List | MeRIP-seq | ||
| Transcript ID List | ENST00000411453.2 | ||
| External Link | RMBase: m6A_site_536261 | ||
| mod ID: M6ASITE053539 | Click to Show/Hide the Full List | ||
| mod site | chr20:50176300-50176301:+ | [4] | |
| Sequence | GGACACATTCCAGCAAAAAGACACAAAGTGACAGAATGGCT | ||
| Motif Score | 2.897386905 | ||
| Cell/Tissue List | Huh7 | ||
| Seq Type List | MeRIP-seq | ||
| Transcript ID List | ENST00000411453.2 | ||
| External Link | RMBase: m6A_site_536262 | ||
References